Jabbour, E., Branford, S., Saglio, G., Jones, D., Cortes, J. E., & Kantarjian, H. M. (2010). Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia.
Chicago ZitierstilJabbour, Elias, Susan Branford, Giuseppe Saglio, Dan Jones, Jorge E. Cortes, und Hagop M. Kantarjian. Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia. 2010.
MLA ZitierstilJabbour, Elias, et al. Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia. 2010.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.